Cyclophilin a is a promising predictor of coronary artery disease

Circulation Journal

Volumn 77, Issue 2, 2013, Pages 321-322

  Taguchi, Isao ^a   Abe, Shichiro ^a   Inoue, Teruo ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYCLOPHILIN A; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GELATINASE A; GELATINASE B; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; LOW DENSITY LIPOPROTEIN RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; REACTIVE OXYGEN METABOLITE; STROMELYSIN; TROPONIN T; TUMOR NECROSIS FACTOR ALPHA;

ACUTE CORONARY SYNDROME; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DISEASE SEVERITY; EDITORIAL; HUMAN; INFLAMMATION; OXIDATIVE STRESS; PREDICTION; PROTEIN EXPRESSION; RISK FACTOR; SMOOTH MUSCLE FIBER;

CORONARY ARTERY DISEASE; CORONARY STENOSIS; CYCLOPHILIN A; FEMALE; HUMANS; MALE; SEVERITY OF ILLNESS INDEX;

EID: 84873857528     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-12-1519     Document Type: Editorial

References (14)

1. Inoue T, Node K. Vascular failure: A new clinical entity for vascular disease. J Hypertens 2006; 24: 2121-2130.
2. Vasan RS. Biomarkers of cardiovascular disease: Molecular basis and practical considerations. Circulation 2006; 113: 2335-2362.
3. Satoh K, Fukumoto Y, Sugimura K, Miura Y, Aoki T, Nochioka K, et al. Plasma cyclophilin A is a novel biomarker for coronary artery disease. Circ J 2013; 77: 447-455.
4. Handschumacher RE, Harding MW, Rice J, Drugge RJ, Speicher DW. Cyclophilin: A specific cytosolic binding protein for cyclosporine A. Science 1984; 226: 544-547.
5. Satoh K, Shimokawa H, Berk BC. Cyclophilin A: Promising new target in cardiovascular therapy. Circ J 2010; 74: 2249-2256.
6. Satoh K, Nigro P, Matoba T, O'Dell MR, Cui Z, Shi X, et al. Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II-induced aortic aneurysms. Nat Med 2009; 15: 649-656.
7. Kovarnik T, Mintz GS, Skalicka H, Kral A, Horak J, Skulec R, et al. Virtual histology evaluation of atherosclerosis regression during atorvastatin and ezetimibe administration: HEAVEN study. Circ J 2012; 76: 176-183.
8. Libby P, Okamoto Y, Rocha VZ, Folco E. Inflammation in atherosclerosis: Transition from theory to practice. Circ J 2010; 74: 213-220.
9. Satoh K, O'Dell MR, Liao DF, Cui Z, Nigro P, Mohan A, et al. Cyclophilin A is a novel proinflammatory cytokine that accelerates development of atherosclerosis. Circulation 2008; 118: S309-S310.
10. Inoue T, Kato T, Takayanagi K, Uchida T, Yaguchi I, Kamishirado H, et al. Circulating matrix metalloproteinase-1 and-3 in patients with acute coronary syndrome. Am J Cardiol 2003; 92: 1461-1464.
11. Kai H, Ikeda H, Yasukawa H, Kai M, Seki Y, Kuwahara F, et al. Peripheral blood levels of matrix metalloproteinase-2 and -9 are elevated in patients with acute coronary syndrome. J Am Coll Cardiol 1998; 32: 368-372.
12. Kobayashi N, Hata N, Kume N, Seino Y, Inami T, Yokoyama S, et al. Soluble lectin-like oxidized low-density lipoprotein receptor-1 as an early biomarker for ST elevation myocardial infarction: Time dependent comparison with other biomarkers. Circ J 2011; 75: 1433-1439.
13. Kobayashi N, Hata N, Kume N, Shinada T, Tomita K, Shirakabe A, et al. Soluble lectin-like oxidized LDL receptor-1 and high-sensitivity troponin T as diagnostic biomarkers for acute coronary syndrome: Improved values with combination usage in emergency rooms. Circ J 2011; 75: 2862-2871.
14. Niwano S, Niwano H, Sasaki S, Fukaya H, Yuge M, Imaki R, et al. N-acetylcysteine suppresses the progression of ventricular remodeling in acute myocarditis: Studies in an experimental autoimmune myocarditis (EAM) model. Circ J 2011; 75: 662-671.